Thursday, August 27

Business & Finance

Moderna (NASDAQ:MRNA), an mRNA medicine and preventive vaccines provider, closed at $174.38, up 176.97%. Shares surged after Moderna and Merckreported positive Phase 3 melanoma data. Investors are watching for FDA plans and further developments for the treatment. Trading volume reached 185.1M shares, coming in about 1,819% above its three-month average of 9.6M shares. Moderna IPO’d…

Economy News

On August 20, Atour Lifestyle Holdings (NASDAQ:ATAT) held its second-quarter earnings call, and the numbers made clear why the stock has become one of the more closely watched Chinese consumer names this year. Net revenues jumped 41.4% year over year to RMB 3,490 million, with both the hotel and retail arms of the business accelerating…

Top Trending